March 24, 2026

Responses to Initial Pembrolizumab Support Treatment De-escalation in Cutaneous Squamous Cell Carcinoma

A response-adapted approach to treatment decision-making for patients with resectable cutaneous squamous cell carcinoma demonstrated that with the use of neoadjuvant pembrolizumab, many patients could...

The ASCO Post

March 23, 2026

AI Model Differentiates BCC vs cSCC Subtypes

External validation identifies calibration shift in COBRA cohort.

Conexiant

March 23, 2026

Collagen Linked to Skin, Joint Benefits

A large umbrella review of randomized trials found the strongest evidence for improvements in skin elasticity and osteoarthritis symptoms.

Conexiant

March 20, 2026

A Case for Reframing ‘Skin of Color’

The term that transformed dermatology is now blurring the very distinctions it was meant to sharpen.

Conexiant

March 18, 2026

FDA Approves New Oral Option for Plaque Psoriasis

Phase 3 data showed high skin clearance rates and adverse event rates similar to placebo through week 16 with once-daily icotrokinra.

Conexiant

March 18, 2026

Can Peptides Improve Skin Aging?

Systematic review reports gains in hydration, brightness, and wrinkles, with stronger evidence for oral vs topical formulations

Conexiant

March 16, 2026

Sunscreen Costs Vary Up to 36-Fold

Economic analysis finds large differences in the annual cost of recommended sunscreen use depending on product price and clothing-based sun protection strategies

Conexiant

March 13, 2026

FDA Approves Secukinumab for Adolescents With Moderate to Severe Hidradenitis Suppurativa

Secukinumab becomes the only interleukin-17A inhibitor approved for pediatric patients aged 12 years and older with moderate to severe hidradenitis suppurativa.

Conexiant

March 12, 2026

Dupilumab Faces Trial in Chronic Hives

Phase III CUPID-C trial evaluates biologic therapy in patients with chronic spontaneous urticaria uncontrolled by antihistamines.

Conexiant

March 12, 2026

ACP Calls for Sweeping Policy Shifts on Disability in Medicine

Twin policy statements in Annals of Internal Medicine outline structural reforms aimed at improving health care access for patients with disabilities and supporting physicians with disabilities in training and practice.

Conexiant